Abzena plc announced its wholly-owned subsidiary Antitope Limited has extended its relationship with INSERM, ANRS and the Baylor Institute for Immunology Research (“BIIR”. INSERM-ANRS and the BIIR have developed innovative approaches for HIV vaccines targeting HIV antigens to dendritic cell ... more
To use all functions of this page, please activate cookies in your browser.